Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for FANAPT (iloperidone) from Vanda Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fanapt (iloperidone)

Snippet

SUPPL AP for FANAPT (ILOPERIDONE)